Cargando…
TRPS1 regulates the opposite effect of progesterone via RANKL in endometrial carcinoma and breast carcinoma
Medroxyprogesterone (MPA) has therapeutic effect on endometrial carcinoma (EC), while it could promote the carcinogenesis of breast cancer (BC) by activating receptor activator of NF-kB ligand (RANKL). However, the selective mechanism of MPA in endometrium and breast tissue remains obscure. Multiomi...
Autores principales: | Yang, Linlin, Fan, Qiong, Wang, Jing, Yang, Xiaoming, Yuan, Jiangjing, Li, Yuhong, Sun, Xiao, Wang, Yudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284899/ https://www.ncbi.nlm.nih.gov/pubmed/37344459 http://dx.doi.org/10.1038/s41420-023-01484-0 |
Ejemplares similares
-
Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
por: Li, Dong, et al.
Publicado: (2021) -
Clinical prognostic significance and pro-metastatic activity of RANK/RANKL via the AKT pathway in endometrial cancer
por: Wang, Jing, et al.
Publicado: (2015) -
TRPs in Pain Sensation
por: Jardín, Isaac, et al.
Publicado: (2017) -
Progesterone Regulates Glucose Metabolism Through Glucose Transporter 1 to Promote Endometrial Receptivity
por: Zhang, Hongshuo, et al.
Publicado: (2020) -
CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells
por: Liu, Yao, et al.
Publicado: (2016)